It revealed that HMGA1 gene alterations were stated in only 1.1% of lung cancer patients profiled for copy number changes, mutations, and structural variants of the gene, namely in about 1.5% of lung adenocarcinoma and 0.5% of lung squamous cell carcinoma cases. This evidence concerns the gene HMGA1 and lung carcinoma.